Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 525

1.

Predictors of progression in systemic sclerosis patients with interstitial lung disease.

Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP, Distler JHW, Hoffmann-Vold AM, Johnson SR, Müller Ladner U, Smith V, Volkmann ER, Maher TM.

Eur Respir J. 2020 Feb 20. pii: 1902026. doi: 10.1183/13993003.02026-2019. [Epub ahead of print] Review.

PMID:
32079645
2.

[Model project on interdisciplinary university teaching-medical and psychology students learn together for the first time].

Hasseli R, Pfeiffer S, Kappesser J, Hermann C, Richter-Bastian K, Sattler T, Tschernatsch M, Hoffmann U, Müller-Ladner U, Lange U.

Z Rheumatol. 2020 Feb 10. doi: 10.1007/s00393-020-00749-8. [Epub ahead of print] German.

PMID:
32040754
3.

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.

Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, Aletaha D, Aringer M, Askling J, Balsa A, Boers M, den Broeder AA, Buch MH, Buttgereit F, Caporali R, Cardiel MH, De Cock D, Codreanu C, Cutolo M, Edwards CJ, van Eijk-Hustings Y, Emery P, Finckh A, Gossec L, Gottenberg JE, Hetland ML, Huizinga TWJ, Koloumas M, Li Z, Mariette X, Müller-Ladner U, Mysler EF, da Silva JAP, Poór G, Pope JE, Rubbert-Roth A, Ruyssen-Witrand A, Saag KG, Strangfeld A, Takeuchi T, Voshaar M, Westhovens R, van der Heijde D.

Ann Rheum Dis. 2020 Jan 22. pii: annrheumdis-2019-216655. doi: 10.1136/annrheumdis-2019-216655. [Epub ahead of print]

4.

Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis.

Smith V, Herrick AL, Ingegnoli F, Damjanov N, De Angelis R, Denton CP, Distler O, Espejo K, Foeldvari I, Frech T, Garro B, Gutierrez M, Gyger G, Hachulla E, Hesselstrand R, Iagnocco A, Kayser C, Melsens K, Müller-Ladner U, Paolino S, Pizzorni C, Radic M, Riccieri V, Snow M, Stevens W, Sulli A, van Laar JM, Vonk MC, Vanhaecke A, Cutolo M; EULAR Study Group on Microcirculation in Rheumatic Diseases and the Scleroderma Clinical Trials Consortium Group on Capillaroscopy.

Autoimmun Rev. 2020 Jan 10:102458. doi: 10.1016/j.autrev.2020.102458. [Epub ahead of print] Review.

5.

Evaluation of a special concept of physical therapy in spondyloarthritis: German multimodal rheumatologic complex treatment for spondyloarthritis.

Klemm P, Hudowenz O, Asendorf T, Dischereit G, Müller-Ladner U, Lange U, Tarner IH.

Clin Rheumatol. 2020 Jan 8. doi: 10.1007/s10067-019-04887-6. [Epub ahead of print]

PMID:
31916106
6.

Free Fatty Acids in Bone Pathophysiology of Rheumatic Diseases.

Frommer KW, Hasseli R, Schäffler A, Lange U, Rehart S, Steinmeyer J, Rickert M, Sarter K, Zaiss MM, Culmsee C, Ganjam G, Michels S, Müller-Ladner U, Neumann E.

Front Immunol. 2019 Dec 3;10:2757. doi: 10.3389/fimmu.2019.02757. eCollection 2019.

7.

Inhomogeneity of capillaroscopic findings in systemic sclerosis.

Lambova SN, Müller-Ladner U.

Int J Rheum Dis. 2020 Feb;23(2):207-215. doi: 10.1111/1756-185X.13760. Epub 2019 Dec 5.

PMID:
31808306
8.

[56-year old patient with inflammatory back pain].

Schulz N, Müller-Ladner U, Klemm P.

Dtsch Med Wochenschr. 2019 Dec;144(24):1737-1738. doi: 10.1055/a-0894-1344. Epub 2019 Dec 2. German. No abstract available.

PMID:
31791081
9.

Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort.

Mihai C, Distler O, Gheorghiu AM, Constantin PI, Dobrota R, Jordan S, Smith V, Hachulla E, Henes J, Siegert E, Vettori S, Müller-Ladner U, Matucci Cerinic M, Allanore Y; EUSTAR .

Rheumatology (Oxford). 2019 Dec 2. pii: kez558. doi: 10.1093/rheumatology/kez558. [Epub ahead of print]

PMID:
31790136
10.

[Treatment of systemic sclerosis-associated interstitial lung disease].

Prasse A, Bonella F, Müller-Ladner U, Witte T, Hunzelmann N, Distler J.

Z Rheumatol. 2019 Nov 21. doi: 10.1007/s00393-019-00724-y. [Epub ahead of print] Review. German.

PMID:
31754786
11.

Effects of testosterone and 17β-estradiol on osteogenic and adipogenic differentiation capacity of human bone-derived mesenchymal stromal cells of postmenopausal women.

Glenske K, Schuler G, Arnhold S, Elashry MI, Wagner AS, Barbeck M, Neumann E, Müller-Ladner U, Schnettler R, Wenisch S.

Bone Rep. 2019 Oct 21;11:100226. doi: 10.1016/j.bonr.2019.100226. eCollection 2019 Dec.

12.

Racial differences in systemic sclerosis disease presentation: a European Scleroderma Trials and Research group study.

Jaeger VK, Tikly M, Xu D, Siegert E, Hachulla E, Airò P, Valentini G, Matucci Cerinic M, Distler O, Cozzi F, Carreira P, Allanore Y, Müller-Ladner U, Ananieva LP, Balbir-Gurman A, Distler JHW, Czirják L, Li M, Henes J, Jimenez SA, Smith V, Damjanov N, Denton CP, DelGaldo F, Saketkoo LA, Walker UA; EUSTAR co-authors .

Rheumatology (Oxford). 2019 Nov 4. pii: kez486. doi: 10.1093/rheumatology/kez486. [Epub ahead of print]

PMID:
31680161
13.

Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): a systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD.

Furer V, Rondaan C, Heijstek M, van Assen S, Bijl M, Agmon-Levin N, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, Ladefoged de Thurah A, Landewé R, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O.

RMD Open. 2019 Sep 19;5(2):e001041. doi: 10.1136/rmdopen-2019-001041. eCollection 2019.

14.

Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.

Rondaan C, Furer V, Heijstek MW, Agmon-Levin N, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, Ladefoged de Thurah A, Landewé R, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, van Assen S, Elkayam O.

RMD Open. 2019 Sep 9;5(2):e001035. doi: 10.1136/rmdopen-2019-001035. eCollection 2019.

15.

Fast track algorithm: How to differentiate a "scleroderma pattern" from a "non-scleroderma pattern".

Smith V, Vanhaecke A, Herrick AL, Distler O, Guerra MG, Denton CP, Deschepper E, Foeldvari I, Gutierrez M, Hachulla E, Ingegnoli F, Kubo S, Müller-Ladner U, Riccieri V, Sulli A, van Laar JM, Vonk MC, Walker UA, Cutolo M; EULAR Study Group on Microcirculation in Rheumatic Diseases.

Autoimmun Rev. 2019 Nov;18(11):102394. doi: 10.1016/j.autrev.2019.102394. Epub 2019 Sep 11.

16.

The Adipokine Network in Rheumatic Joint Diseases.

Carrión M, Frommer KW, Pérez-García S, Müller-Ladner U, Gomariz RP, Neumann E.

Int J Mol Sci. 2019 Aug 22;20(17). pii: E4091. doi: 10.3390/ijms20174091. Review.

17.

2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases.

Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, Breedveld FC, D'Amelio R, Dougados M, Kapetanovic MC, van Laar JM, de Thurah A, Landewé RB, Molto A, Müller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O.

Ann Rheum Dis. 2020 Jan;79(1):39-52. doi: 10.1136/annrheumdis-2019-215882. Epub 2019 Aug 14.

PMID:
31413005
18.

An Unusual Cause of Hip Pain.

Lange U, Müller-Ladner U.

Dtsch Arztebl Int. 2019 Jun 10;116(23-24):412. doi: 10.3238/arztebl.2019.0412b. No abstract available.

19.

[Hand ischemia and increased CRP level in a 75-year-old female patient].

Decker E, Basten O, Librizzi D, Müller-Ladner U.

Z Rheumatol. 2019 Jun 13. doi: 10.1007/s00393-019-0655-2. [Epub ahead of print] German.

PMID:
31197459
20.

The activin-follistatin anti-inflammatory cycle is deregulated in synovial fibroblasts.

Diller M, Frommer K, Dankbar B, Tarner I, Hülser ML, Tsiklauri L, Hasseli R, Sauerbier M, Pap T, Rehart S, Müller-Ladner U, Neumann E.

Arthritis Res Ther. 2019 Jun 10;21(1):144. doi: 10.1186/s13075-019-1926-7.

21.

Large variability of frequency and type of physical therapy in patients of the German Network for Systemic Sclerosis.

Belz D, Moinzadeh P, Riemekasten G, Henes J, Müller-Ladner U, Blank N, Koetter I, Siegert E, Pfeiffer C, Schmalzing M, Zeidler G, Schmeiser T, Worm M, Guenther C, Susok L, Kreuter A, Sunderkoetter C, Juche A, Aberer E, Gaebelein-Wissing N, Ramming A, Kuhr K, Hunzelmann N.

Arthritis Care Res (Hoboken). 2019 May 31. doi: 10.1002/acr.23998. [Epub ahead of print]

PMID:
31150152
22.

Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study.

Blagojevic J, Abignano G, Avouac J, Cometi L, Frerix M, Bellando-Randone S, Guiducci S, Bruni C, Huscher D, Jaeger VK, Lóránd V, Maurer B, Nihtyanova S, Riemekasten G, Siegert E, Tarner IH, Vettori S, Walker UA, Czirják L, Denton CP, Distler O, Allanore Y, Müller-Ladner U, Moggi-Pignone A, Matucci-Cerinic M, Del Galdo F; EUSTAR co-workers.

Clin Rheumatol. 2020 Jan;39(1):27-36. doi: 10.1007/s10067-019-04564-8. Epub 2019 May 20.

PMID:
31111363
23.

[41-Year Old Patient with Facial Swelling and Arthralgia].

Schulz N, Müller-Ladner U, Klemm P.

Dtsch Med Wochenschr. 2019 May;144(9):585-586. doi: 10.1055/a-0822-7584. Epub 2019 Apr 26. German. No abstract available.

PMID:
31026866
24.

A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity.

Karnell JL, Albulescu M, Drabic S, Wang L, Moate R, Baca M, Oganesyan V, Gunsior M, Thisted T, Yan L, Li J, Xiong X, Eck SC, de Los Reyes M, Yusuf I, Streicher K, Müller-Ladner U, Howe D, Ettinger R, Herbst R, Drappa J.

Sci Transl Med. 2019 Apr 24;11(489). pii: eaar6584. doi: 10.1126/scitranslmed.aar6584.

PMID:
31019027
25.

Capillaroscopic features of microangiopathy in rheumatoid arthritis patients with peripheral vascular syndrome.

Lambova SN, Müller-Ladner U.

Clin Rheumatol. 2019 Sep;38(9):2339-2341. doi: 10.1007/s10067-019-04561-x. Epub 2019 Apr 24. No abstract available.

PMID:
31016582
26.

Targeting Activated Synovial Fibroblasts in Rheumatoid Arthritis by Peficitinib.

Diller M, Hasseli R, Hülser ML, Aykara I, Frommer K, Rehart S, Müller-Ladner U, Neumann E.

Front Immunol. 2019 Mar 26;10:541. doi: 10.3389/fimmu.2019.00541. eCollection 2019.

27.

Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication.

Moinzadeh P, Kuhr K, Siegert E, Blank N, Sunderkoetter C, Henes J, Krusche M, Schmalzing M, Worm M, Schmeiser T, Günther C, Aberer E, Susok L, Riemekasten G, Kreuter A, Zeidler G, Juche A, Hadjiski D, Müller-Ladner U, Gaebelein-Wissing N, Distler JHW, Sárdy M, Krieg T, Hunzelmann N.

J Rheumatol. 2020 Feb;47(2):241-248. doi: 10.3899/jrheum.180582. Epub 2019 Apr 1.

PMID:
30936287
28.

Effects of BI 655064, an antagonistic anti-CD40 antibody, on clinical and biomarker variables in patients with active rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase IIa study.

Visvanathan S, Daniluk S, Ptaszyński R, Müller-Ladner U, Ramanujam M, Rosenstock B, Eleftheraki AG, Vinisko R, Petříková A, Kellner H, Dokoupilova E, Kwiatkowska B, Alten R, Schwabe C, Baum P, Joseph D, Fine JS, Padula SJ, Steffgen J.

Ann Rheum Dis. 2019 Jun;78(6):754-760. doi: 10.1136/annrheumdis-2018-214729. Epub 2019 Mar 22.

29.

Impfen bei Immundefizienz : Anwendungshinweise zu den von der Ständigen Impfkommission empfohlenen Impfungen. (IV) Impfen bei Autoimmunkrankheiten, bei anderen chronisch-entzündlichen Erkrankungen und unter immunmodulatorischer Therapie.

Wagner N, Assmus F, Arendt G, Baum E, Baumann U, Bogdan C, Burchard G, Föll D, Garbe E, Hecht J, Müller-Ladner U, Niehues T, Überla K, Vygen-Bonnet S, Weinke T, Wiese-Posselt M, Wojcinski M, Zepp F.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2019 Apr;62(4):494-515. doi: 10.1007/s00103-019-02905-1. German. No abstract available.

PMID:
30899964
30.

Effectiveness and safety of anti-tumour necrosis factor therapy with certolizumab pegol observed in real-life rheumatoid arthritis patients in Germany: results from the non-interventional FαsT study.

Burmester G, Nüsslein H, von Hinüber U, Detert J, Richter C, Kumke T, Leunikava I, Lendl U, Fricke D, Müller-Ladner U.

Clin Exp Rheumatol. 2019 Sep-Oct;37(5):842-851. Epub 2019 Mar 7.

PMID:
30873942
31.

Adipokine expression in systemic sclerosis lung and gastrointestinal organ involvement.

Neumann E, Lepper N, Vasile M, Riccieri V, Peters M, Meier F, Hülser ML, Distler O, Gay S, Mahavadi P, Günther A, Roeb E, Frommer KW, Diller M, Müller-Ladner U.

Cytokine. 2019 May;117:41-49. doi: 10.1016/j.cyto.2018.11.013. Epub 2019 Feb 19.

PMID:
30784899
32.

Reply to 'Moyamoya vasculopathy with anti-SCL-70 antibodies: A case report and review of the literature'.

Wegner F, Müller-Ladner U, Meier FM.

J Clin Neurosci. 2019 May;63:281. doi: 10.1016/j.jocn.2019.01.043. Epub 2019 Feb 4. No abstract available.

PMID:
30732990
33.

[Multimodal rheumatologic complex treatment of rheumatoid arthritis-a monocentric retrospective analysis].

Klemm P, Hudowenz O, Asendorf T, Müller-Ladner U, Lange U, Tarner IH.

Z Rheumatol. 2019 Mar;78(2):136-142. doi: 10.1007/s00393-019-0593-z. German.

PMID:
30715601
34.

Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher/European Scleroderma Trials and Research group (EUSTAR) survey.

Blagojevic J, Bellando-Randone S, Abignano G, Avouac J, Cometi L, Czirják L, Denton CP, Distler O, Frerix M, Guiducci S, Huscher D, Jaeger VK, Lóránd V, Maurer B, Nihtyanova S, Riemekasten G, Siegert E, Tarner IH, Vettori S, Walker UA, Allanore Y, Müller-Ladner U, Del Galdo F, Matucci-Cerinic M; EUSTAR co-workers.

Arthritis Res Ther. 2019 Jan 24;21(1):35. doi: 10.1186/s13075-019-1822-1.

35.

[Effects of serial mud baths on inflammatory rheumatic and degenerative diseases].

Dischereit G, Goronzy JE, Müller-Ladner U, Fetaj S, Lange U.

Z Rheumatol. 2019 Mar;78(2):143-154. doi: 10.1007/s00393-018-0582-7. German.

PMID:
30627845
36.

The Role of Extracellular Nucleic Acids in Rheumatoid Arthritis.

Neumann E, Hasseli R, Lange U, Müller-Ladner U.

Curr Pharm Biotechnol. 2018;19(15):1182-1188. doi: 10.2174/1389201020666190102150216. Review.

PMID:
30605055
37.

Correction to: Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups.

Najm A, Le Goff B, Orr C, Thurlings R, Cañete JD, Humby F, Alivernini S, Manzo A, Just SA, Romão VC, Krenn V, Müller-Ladner U, Addimanda O, Tas SW, Stoenoiu M, de Bellefon LM, Durez P, Strand V, Wechalekar MD, Fonseca JE, Lauwerys B, Fearon U, Veale DJ; EULAR Synovitis Study Group and OMERACT Synovial Tissue Special Interest Group.

Arthritis Res Ther. 2018 Dec 19;20(1):282. doi: 10.1186/s13075-018-1795-5.

38.

Evidence of an anti-inflammatory toll-like receptor 9 (TLR 9) pathway in adipocytes.

Thomalla M, Schmid A, Neumann E, Pfefferle PI, Müller-Ladner U, Schäffler A, Karrasch T.

J Endocrinol. 2019 Feb 1;240(2):325-343. doi: 10.1530/JOE-18-0326.

PMID:
30508414
39.

Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups.

Najm A, Le Goff B, Orr C, Thurlings R, Cañete JD, Humby F, Alivernini S, Manzo A, Just SA, Romão VC, Krenn V, Müller-Ladner U, Addimanda O, Tas SW, Stoenoiu M, Meric de Bellefon L, Durez P, Strand V, Wechalekar MD, Fonseca JE, Lauwerys B, Fearon U, Veale DJ; EULAR Synovitis Study Group and OMERACT Synovial Tissue Special Interest Group.

Arthritis Res Ther. 2018 Dec 3;20(1):265. doi: 10.1186/s13075-018-1762-1. Erratum in: Arthritis Res Ther. 2018 Dec 19;20(1):282.

40.

Mixed connective tissue disease: state of the art on clinical practice guidelines.

Chaigne B, Scirè CA, Talarico R, Alexander T, Amoura Z, Avcin T, Beretta L, Doria A, Guffroy A, Guimarães V, Hachulla É, Krieg T, Launay D, Lepri G, Moinzadeh P, Müller-Ladner U, Rednic S, Rodrigues A, Tas SW, van Vollenhoven RF, Vieira A, Bombardieri S, Fonseca JE, Galetti I, Schneider M, Smith V, Cutolo M, Mosca M, Fischer-Betz R.

RMD Open. 2018 Oct 18;4(Suppl 1):e000783. doi: 10.1136/rmdopen-2018-000783. eCollection 2018.

41.

Rituximab in routine care of severe active rheumatoid arthritis : A prospective, non-interventional study in Germany.

Krause A, Aries PM, Berger S, Fiehn C, Kellner H, Lorenz HM, Meier L, Müller GA, Müller-Ladner U, Schwarting A, Tony HP, Peters MA, Wendler J.

Z Rheumatol. 2019 Nov;78(9):881-888. doi: 10.1007/s00393-018-0552-0.

PMID:
30276727
42.

Interactions between rheumatoid arthritis synovial fibroblast migration and endothelial cells.

Zimmermann-Geller B, Köppert S, Kesel N, Hasseli R, Ullrich S, Lefèvre S, Frommer K, Gehrke T, Schönburg M, Rehart S, Schumacher U, Müller-Ladner U, Neumann E.

Immunol Cell Biol. 2019 Feb;97(2):178-189. doi: 10.1111/imcb.12208. Epub 2018 Nov 2.

PMID:
30252968
43.

[In-label in rheumatology-what is actually allowed?]

Müller-Ladner U.

Z Rheumatol. 2018 Sep;77(7):557-558. doi: 10.1007/s00393-018-0491-9. German. No abstract available.

PMID:
30171403
44.

Osteoarthritis - Current Insights in Pathogenesis, Diagnosis and Treatment.

Lambova SN, Müller-Ladner U.

Curr Rheumatol Rev. 2018;14(2):91-97. doi: 10.2174/157339711402180706144757. Review. No abstract available.

PMID:
30003854
45.

[Rheumatoid arthritis].

Neumann E, Frommer K, Diller M, Müller-Ladner U.

Z Rheumatol. 2018 Nov;77(9):769-775. doi: 10.1007/s00393-018-0500-z. Review. German.

PMID:
29974224
46.

[S2e guideline: treatment of rheumatoid arthritis with disease-modifying drugs].

Fiehn C, Holle J, Iking-Konert C, Leipe J, Weseloh C, Frerix M, Alten R, Behrens F, Baerwald C, Braun J, Burkhardt H, Burmester G, Detert J, Gaubitz M, Gause A, Gromnica-Ihle E, Kellner H, Krause A, Kuipers J, Lorenz HM, Müller-Ladner U, Nothacker M, Nüsslein H, Rubbert-Roth A, Schneider M, Schulze-Koops H, Seitz S, Sitter H, Specker C, Tony HP, Wassenberg S, Wollenhaupt J, Krüger K.

Z Rheumatol. 2018 Aug;77(Suppl 2):35-53. doi: 10.1007/s00393-018-0481-y. Review. German.

PMID:
29968101
47.

Visfatin alters the cytokine and matrix-degrading enzyme profile during osteogenic and adipogenic MSC differentiation.

Tsiklauri L, Werner J, Kampschulte M, Frommer KW, Berninger L, Irrgang M, Glenske K, Hose D, El Khassawna T, Pons-Kühnemann J, Rehart S, Wenisch S, Müller-Ladner U, Neumann E.

Osteoarthritis Cartilage. 2018 Sep;26(9):1225-1235. doi: 10.1016/j.joca.2018.06.001. Epub 2018 Jun 14.

48.

Dr. Wegner, et al, reply.

Wegner F, Müller-Ladner U, Meier FMP.

J Rheumatol. 2018 Jun;45(6):875. doi: 10.3899/jrheum.171439. No abstract available.

PMID:
29858457
49.

Brief Report: Smoking in Systemic Sclerosis: A Longitudinal European Scleroderma Trials and Research Group Study.

Jaeger VK, Valentini G, Hachulla E, Cozzi F, Distler O, Airó P, Czirják L, Allanore Y, Siegert E, Rosato E, Matucci-Cerinic M, Caimmi C, Henes J, Carreira PE, Smith V, Del Galdo F, Denton CP, Ullman S, De Langhe E, Riccieri V, Alegre-Sancho JJ, Rednic S, Müller-Ladner U, Walker UA; EUSTAR coauthors.

Arthritis Rheumatol. 2018 Nov;70(11):1829-1834. doi: 10.1002/art.40557. Epub 2018 Sep 24.

50.

[Rheumatological research networks in Germany].

Müller-Ladner U.

Z Rheumatol. 2018 May;77(Suppl 1):1-3. doi: 10.1007/s00393-018-0473-y. German. No abstract available.

PMID:
29728836

Supplemental Content

Loading ...
Support Center